Evidence map›Paper›PMID 31309744›Full record

ArticlePediatric blood & cancer2019

Mentors' perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology Group.

Adam J Esbenshade, Lisa S Kahalley, Reto Baertschiger, Roshni Dasgupta, Kelly C Goldsmith, Paul C Nathan, Paul Harker-Murray, Carrie L Kitko, Edward Anders Kolb, Erin S Murphy and 8 more

Abstract read
In one paragraph

Article in Pediatric blood & cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Adam J EsbenshadeMonroe Carell Jr. Children's Hospital, Vanderbilt Division of Pediatric Hematology-Oncology and Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.ORCID 0000-0002-0154-4996
Lisa S KahalleyTexas Children's Hospital, Baylor College of Medicine, Houston, Texas.
Reto BaertschigerChildren's Hospital at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Roshni DasguptaCincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
Kelly C GoldsmithChildrens's Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center, Atlanta, Georgia.
Paul C NathanThe Hospital for Sick Children, The University of Toronto, Toronto, Canada.ORCID 0000-0003-0334-0871
Paul Harker-MurrayDivision of Pediatric Hematology-Oncology and Bone Marrow Transplant, Children's Hospital of Wisconsin, Milwaukee, Wisconsin.
Carrie L KitkoMonroe Carell Jr. Children's Hospital, Vanderbilt Division of Pediatric Hematology-Oncology and Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
Edward Anders KolbDivision of Pediatric Hematology-Oncology, Alfred L. duPont Hospital for Children, Wilmington, Delaware.
Erin S MurphyCleveland Clinic, Cleveland, Ohio.
Jodi A MuscalTexas Children's Hospital, Baylor College of Medicine, Houston, Texas.
Christopher R PiersonDepartment of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio.
Damon ReedDivision of Pediatric Hematology-Oncology, Johns Hopkins All Children's Hospital, St. Petersburg, Florida.
Reuven SchoreChildren's National Health System, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
Yoram UnguruDivision of Pediatric Hematology-Oncology, The Children's Hospital at Sinai, Baltimore, Maryland.ORCID 0000-0002-2250-300X
Rajkumar VenkatramaniTexas Children's Hospital, Baylor College of Medicine, Houston, Texas.
Birte WistinghausenChildren's National Health System, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
Girish DhallDivision of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles, Los Angeles, California.

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
COG FOREIGN ACCRUALU10CA098543 · NCI · NATIONAL CHILDHOOD CANCER FOUNDATION · PI ADAMSON, PETER C. · 2003 to 2013
$335.5M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
Children's Oncology Group Statistics &Data Center GrantU10CA098413 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI DEVIDAS, MEENAKSHI · 2003 to 2013
$67.5M
Vanderbilt Clinical Oncology Research Career Development ProgramK12CA090625 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Debra L. Friedman, Paula Jill Hurley · 2001 to 2026
$16.9M
NCI NIH HHS K12 CA090625NCI NIH HHS U10 CA098413NCI NIH HHS U10 CA098543NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899NIH HHS U10CA09543NIH HHS U10CA098413NIH HHS U10CA180886NIH HHS U10CA180899
6 · The paper itself

Abstract

backgroundIdentification and development of young investigators (YI) is critical to the long-term success of research organizations. In 2004, the Children's Oncology Group (COG) created a mentorship program to foster the career development of YIs (faculty <10 years from initial appointment). This study sought to assess mentors' long-term assessment of this program. PROCEDURE: In 2018, 101 past or current mentors in the COG YI mentorship program completed an online survey. Statistical comparisons were made with the Kruskal-Walis test.

resultsThe response rate was 74.2%. As some mentors had multiple mentees, we report on 138 total mentee-mentor pairs. Mentors were 57.4% male, and mentees were 39.1% male. Mentors rated being mentored as a YI as important with a median rating of 90 on a scale of 1-100, interquartile range (IQR) 80-100. Most mentors reported that being mentored themselves helped their own success within COG (78.2%) and with their overall career development (92.1%). Most mentors enjoyed serving in the program (72.3%) and the median success rating (on a scale of 1-100) across the mentor-mentee pairings was 75, IQR 39-90. Success ratings did not differ by mentor/mentee gender, but improved with increased frequency of mentor-mentee interactions (P < .001). Mentor-mentee pairs who set initial goals reported higher success ratings than those who did not (P < .001). Tangible successes included current mentee COG committee involvement (45.7%), ongoing mentor-mentee collaboration (53.6%), and co-authored manuscript publication (38.4%).

conclusionThese data indicate that mentorship is important for successful professional development. Long-term mentoring success improves when mentors and mentees set goals upfront and meet frequently.

Indexed as

Medical OncologyMentoringMentorsFemaleHumansMaleProgram Evaluationcareer developmentChildren's Oncology Groupmentorshippediatric oncology

Identifiers

PMID31309744
PMCPMC6707882

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.